org placeholder image

Daniel Gamboa

Research Associate II at Beam Therapeutics

  • LinkedIn

Email Email: d****@regeneron.com

phone noPhone Number: (***)-***-****

map
BEAM THERAPEUTICS

BEAM THERAPEUTICS

  • description Description
    Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 50 Million to 100 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Beam Therapeutics Org Chart and Mapping

Employees

Brad Dutot

Senior Vice President, Head of Information Technology

Seda Gyonjyan

Senior Research Associate II

Layne Jacobs

Vice President, Corporate Counsel

Damien Fenske-Corbiere

Principal Software/Cloud Engineer

Alexander Liquori

Principal Research Associate

Elaine Wong

Director, Product and Portfolio Strategy, Genetic Diseases

Frequently Asked Questions Regarding Daniel Gamboa

Answer: Daniel Gamboa works for Beam Therapeutics as Research Associate II

Answer: Daniel Gamboa’s role in Beam Therapeutics is Research Associate II

Answer: Daniel Gamboa's email address is d***@gmail.com

Answer: Daniel Gamboa's business email address is d****@regeneron.com

Answer: Daniel Gamboa’s direct phone number is (***)-***-****

Answer: Daniel Gamboa works in the industry of: Biotechnology

Answer: Daniel Gamboa works Beam Therapeutics located at 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States

Answer: Beam Therapeutics's Research Associate II is Daniel Gamboa

Answer: Daniel Gamboa contact details:

  • Phone number  :  (***)-***-****
  • Email  :  d****@regeneron.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access